Unexplained weight loss, a condition characterized by a reduction in body weight that occurs without a clear cause, poses a diagnostic challenge to clinicians. The purpose of this article is to provide a comprehensive approach to evaluating this clinical enigma.
Unexplained weight loss is estimated to account for 15-20% of cases in the elderly population. It is often associated with significant morbidity and mortality, emphasizing the need for prompt diagnosis and intervention.
The differential diagnosis for unexplained weight loss is broad, encompassing gastrointestinal diseases, malignancies, endocrine disorders, and psychiatric conditions. A thorough history and physical examination are essential in narrowing down potential causes.
A stepwise approach is recommended. Initial investigations should include complete blood count, metabolic panel, thyroid function tests, and tumor markers. If these are inconclusive, consider advanced imaging or endoscopy. Tailoring the diagnostic approach based on individual patient factors can enhance efficiency and reduce unnecessary testing.
The management of unexplained weight loss is primarily directed towards the underlying cause. Nutritional support plays a crucial role in all patients, often requiring a multidisciplinary team approach. Pharmacological intervention may be considered in certain cases, following a thorough risk-benefit analysis.
Unexplained weight loss remains a complex clinical problem that warrants a systematic approach to evaluation and management. By understanding the potential causes and adopting a comprehensive diagnostic strategy, clinicians can effectively manage this condition and improve patient outcomes.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation